# A Study of Carbon-14-Labeled LY2835219 ([^14C]-LY2835219) in Healthy Participants

> **NCT01913314** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 6 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** [^14C]-LY2835219

## Key facts

- **NCT ID:** NCT01913314
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01913314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01913314, "A Study of Carbon-14-Labeled LY2835219 ([^14C]-LY2835219) in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01913314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*